People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ENB Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $1.7M | 2023 |
| NapaJen Pharma, Inc. | — | Pharmaceuticals | Pre-Seed | $500K | $12.1M | 2021 |
Walter Olesiak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Walter Olesiak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Taro Inaba | 1 | 4 |
| Albert Sokol | 1 | 2 |
| Barbara Schilberg | 1 | 2 |
| Kazuhiko Nonomura | 1 | 1 |
| Stuart Hwang | 1 | 1 |
| Sumayah Jamal | 1 | 1 |
| Fumitaka Mori | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.